![Anti-CLEC16A [7E10]](https://cancertools.org/wp-content/uploads/72acefb6-3105-45c1-ac49-eb6e10bb48d9.png)
![Anti-CLEC16A [7E10] - Image 2](https://cancertools.org/wp-content/uploads/aaa98a41-3375-4738-9cbe-045449a6c20f.png)
Cat. #158317
Anti-CLEC16A [7E10]
Cat. #: 158317
Unit size: 100 ug
Availability: 10-12 weeks
Target: C-Type Lectin Domain Containing 16A
Class: Monoclonal
Application: ELISA ; FACS ; IHC ; IF ; WB ;DB
Reactivity: Mouse
Host: Rat
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: The University of British Columbia
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-CLEC16A [7E10]
- Alternate name: CLEC16A, KIAA35
- Research fields: Immunology;Neurobiology
- Class: Monoclonal
- Conjugation: Unconjugated
- Reactivity: Mouse
- Host: Rat
- Application: ELISA ; FACS ; IHC ; IF ; WB ;DB
- Description: Antibody against CLEC16A (specifically binds to C-terminal human peptide CLEC16A1,002-1,024: RALSGISQLPTLPAADTETPAEG) CLEC16A is a cytosolic protein which is differentially expressed in human immune cells and is known to be highly expressed on B-lymphocytes, natural killer (NK) and dendritic cells. CLEC16A gene has been linked to several autoimmune diseases, including Addison's disease, diabetes melllitus, Crohn's disease, primary biliary cirrhosis, juvenile idiopathic arthritis, rheumatoid arthritis and multiple sclerosis. . CLEC16A has been shown to regulate various immune pathways including directly regulating leukocyte antigen class II pathway in antigen presenting cells, autophagy, mitophagy, and NK cell cytotoxicity.
- Immunogen: 23-mer C-terminal mouse peptide (CLEC16A1,002-1,024: RALSGISQLPTLPAADTETPAEG) linked to KLH
- Recommended controls: IgG2a
Target Details
- Target: C-Type Lectin Domain Containing 16A
- Target background: antibody against CLEC16A (specifically binds to C-terminal human peptide CLEC16A1,002-1,024: RALSGISQLPTLPAADTETPAEG) CLEC16A is a cytosolic protein which is differentially expressed in human immune cells and is known to be highly expressed on B-lymphocytes, natural killer (NK) and dendritic cells. CLEC16A gene has been linked to several autoimmune diseases, including Addison's disease, diabetes melllitus, Crohn's disease, primary biliary cirrhosis, juvenile idiopathic arthritis, rheumatoid arthritis and multiple sclerosis. . CLEC16A has been shown to regulate various immune pathways including directly regulating leukocyte antigen class II pathway in antigen presenting cells, autophagy, mitophagy, and NK cell cytotoxicity.
Applications
- Application: ELISA ; FACS ; IHC ; IF ; WB ;DB
Handling
- Format: Liquid
- Unit size: 100 ug
- Shipping conditions: Dry ice
